UNSPSC 51285804: Hexamine mandelate

This classification denotes a urinary anti-infective agent with the molecular formula C8H8O3.C6H12N4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 695N30CINR, chemically known as 1,3,5,7-tetraazatricyclo(3.3.1.1(3,7))decane, mono(alpha-hydroxybenzeneacetate) but more generally known as hexamine mandelate, which bears US NIH Compound Identifier 11478. European Medicines Agency schedules Methenamine mandelate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03216MIG.

Most nations schedule hexamine mandelate under HS 29339990. SMILES: C1CCC(CC1)C(C(=O)O)O.C1N2CN3CN1CN(C2)C3.

UNSPSC 51285804 Hexamine mandelate (Commodity) does not align with the pharmaceutical and medical supply procurements recently posted by state and local governments under this code. The recent opportunities tagged to this code—naloxone, drug deactivation systems, emergency medical supplies, and multi-source generic pharmaceuticals—represent broad pharmacy benefit and first-responder health procurement, not hexamine mandelate as a specific active pharmaceutical ingredient. State and local buyers under this code are acquiring finished pharmaceutical products, OTC items, and medical consumables for fire rescue operations, community health programs, and employee health plans, typically in bulk quantities with quarterly or annual delivery cycles and fixed pricing models.

Issuing bodies include county health departments (Seminole County, Florida), municipal fire services (City of Tampa), state health agencies (Texas HHS Commission), and cooperative purchasing alliances serving multiple state and local jurisdictions (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). Geographically, recent activity spans Florida, Texas, Minnesota, and Oregon through cooperative buying arrangements. Representative recent opportunities include Seminole County's IFB 60459723LAS for 1,900 units of naloxone and 800 drug deactivation systems annually (response due July 26, 2023); the City of Tampa's IFB 26-P-00145 for medical and first aid supplies for the Fire Department Rescue Division, estimated at $700,000 with a 5% SLBE discount (due March 13, 2026); Texas HHS Commission's RFI HHS0017013 on direct-to-manufacturer pharmacy prescription programs (due April 3, 2026); and MMCAP's RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products to authorized wholesalers (due March 26, 2026, effective July 1, 2026). The code shows active procurement volume but with limited direct relevance to hexamine mandelate specifically.